The Conversation (0)
- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
Enzymotec Ltd. To Present at Two Upcoming Investor Conferences
Aug. 02, 2016 08:28AM PST
Biotech InvestingAugust 02, 2016 08:30 ET | Source:Enzymotec Ltd. MIGDAL HA’EMEQ, Israel, Aug. 02, 2016 (GLOBE NEWSWIRE) — Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that Dr. Ariel Katz, the Company’s Chief Executive Officer, is scheduled to present at the Jefferies Industrial Conference, …
August 02, 2016 08:30 ET
| Source:Enzymotec Ltd.
MIGDAL HA’EMEQ, Israel, Aug. 02, 2016 (GLOBE NEWSWIRE) — Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that Dr. Ariel Katz, the Company’s Chief Executive Officer, is scheduled to present at the Jefferies Industrial Conference, being held August 9 – 11, 2016 in New York City and the Canaccord Genuity Annual Growth Conference, being held August 10 – 11, 2016 in Boston.
Details for the Company presentation are as follows:
| Conference: | Jefferies Industrial Conference | |
| Date: | Wednesday, August 10, 2016 | |
| Time: | 10:40AM ET | |
| Conference: | Canaccord Genuity Annual Growth Conference | |
| Date: | Thursday, August 11, 2016 | |
| Time: | 10:30AM ET | |
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures, and markets innovative bio-active lipid based nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies intended to improve people’s health. For more information, visit www.enzymotec.com.
Contact: The Ruth Group Tram Bui / Lee Roth (646) 536-7035/7012 tbui@theruthgroup.com lroth@theruthgroup.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.